Alembic Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 05, 2025
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals held its 15th AGM on August 5, 2025 via video conferencing, attended by all directors and 80 members. Key items included adoption of audited standalone and consolidated financial statements for FY ending March 31, 2025, and declaration of a dividend on equity shares for FY 2024-25. Two special resolutions were passed: appointment of Mr. Chirayu Amin as Executive Chairman and re-appointment of Mr. Pranav Amin as Managing Director. Other items covered re-appointment of Mr. Shaunak Amin, statutory and secretarial auditor appointments, commission for non-executive directors, and ratification of cost auditors' remuneration. The meeting concluded in about 24 minutes, with voting results to be declared on or before August 7, 2025.
This is a routine compliance filing confirming the AGM was held. Investors should look out for the voting results on the dividend, auditor appointments, and executive re-appointments, which will be released by August 7, 2025.